Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Katia Lefsihane"'
Autor:
Véronique Barateau, Loïc Peyrot, Carla Saade, Bruno Pozzetto, Karen Brengel-Pesce, Mad-Hélénie Elsensohn, Omran Allatif, Nicolas Guibert, Christelle Compagnon, Natacha Mariano, Julie Chaix, Sophia Djebali, Jean-Baptiste Fassier, Bruno Lina, Katia Lefsihane, Maxime Espi, Olivier Thaunat, Jacqueline Marvel, Manuel Rosa-Calatrava, Andres Pizzorno, Delphine Maucort-Boulch, Laetitia Henaff, Mitra Saadatian-Elahi, Philippe Vanhems, Stéphane Paul, Thierry Walzer, Sophie Trouillet-Assant, Thierry Defrance
Publikováno v:
Science Translational Medicine
Science Translational Medicine, 2023, 15 (687), 17 p. ⟨10.1126/scitranslmed.ade0550⟩
Science Translational Medicine, 2023, 15 (687), 17 p. ⟨10.1126/scitranslmed.ade0550⟩
The diversity of vaccination modalities and infection history are both variables that have an impact on the immune memory of individuals vaccinated against SARS-CoV-2. To gain more accurate knowledge of how these parameters imprint on immune memory,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00871233a8658a20e13f29c03cc176af
https://hal.science/hal-04144641/file/ris00002274.pdf
https://hal.science/hal-04144641/file/ris00002274.pdf
Autor:
Cristiano Amarelli, Nina Pilat, Olivier Thaunat, Sophie Brouard, Christine S. Falk, Federica Casiraghi, Floriane Fusil, Nuria Montserrat, Katia Lefsihane, Katja Kotsch, Romy Steiner
Publikováno v:
Transplant International. 34:1594-1606
Cell therapy has emerged as an attractive therapeutic option in organ transplantation. During the last decade, the therapeutic potency of Treg immunotherapy has been shown in various preclinical animal models and safety was demonstrated in first clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8f9a01c2871c860eedfc29e21c9ffee
https://doi.org/10.1111/tri.13972
https://doi.org/10.1111/tri.13972
Autor:
Ellen Iacobaeus, Anders Lilja, Katarina Le Blanc, Erik Boberg, Nadir Kadri, Lou Brundin, Caroline Gavin, Katia Lefsihane, Anton Törnqvist Andrén
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine; Volume 8; Issue 12; Pages: 2102
Journal of Clinical Medicine; Volume 8; Issue 12; Pages: 2102
Bone marrow derived mesenchymal stromal cells (BM-MSCs) have emerged as a possible new therapy for Multiple Sclerosis (MS), however studies regarding efficacy and in vivo immune response have been limited and inconclusive. We conducted a phase I clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb85a391ff6913b900f5d524c5de887f
https://pubmed.ncbi.nlm.nih.gov/31810187
https://pubmed.ncbi.nlm.nih.gov/31810187
Autor:
Maritha Marcusson-Ståhl, Dimitrios Mougiakakos, Katarina Le Blanc, Ellen Iacobaeus, Nadir Kadri, Lindsay C. Davies, Anton Törnqvist Andrén, Caroline Gavin, Regina Jitschin, Katia Lefsihane, Iyadh Douagi
Publikováno v:
Immunology and cell biology. 96(8)
Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system involving dysregulated encephalitogenic T cells. Myeloid-derived suppressor cells (MDSCs) have been recognized for their important function in regulating T-cell res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8a3fb43f7cb9b14e7c5e3d84a7ed8cb
https://pubmed.ncbi.nlm.nih.gov/29569304
https://pubmed.ncbi.nlm.nih.gov/29569304